ADC Therapeutics S.A. logo ADCT - ADC Therapeutics S.A.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 4
SELL 1
STRONG
SELL
0
| PRICE TARGET: $5.00 DETAILS
HIGH: $5.00
LOW: $5.00
MEDIAN: $5.00
CONSENSUS: $5.00
UPSIDE: 47.49%

Profitability Ratios

Ratio Value
GP Margin 90.6%
EBIT Margin -133.2%
EBITDA Margin -130.9%
Operating Margin -133.2%
Pretax Margin -175.5%
Cont. Ops Margin -175.3%
Net Margin -175.3%
Bottom Line Margin -175.3%

Liquidity Ratios

Ratio Value
Current Ratio 4.37
Quick Ratio 4.31
Solvency Ratio -0.277
Cash Ratio 3.72

Valuation Ratios

Ratio Value
Price/Earnings
-3.14
Peers avg: 14.2
PEG Ratio 0.10
Forward PEG 0.10
Price/Book -2.41
Price/Sales 5.51
Price/FCF -3.17
Price/Op Cash Flow -3.18

Debt Ratios

Ratio Value
Debt/Assets 1.3585
Debt/Equity -2.3624
Debt/Capital 1.7340
Long-Term Debt/Capital 1.7428
Financial Leverage -1.74

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.35
Operating Cash Flow Ratio -2.012
Operating Cash Flow/Sales -173.5%
Free Cash Flow/Operating Cash Flow 100.2%

Coverage Ratios

Ratio Value
Debt Service Coverage -1.95
Interest Coverage -2.0990
Short-Term Operating Cash Flow Coverage -47.06
Operating Cash Flow Coverage -0.32
Capital Expenditure Coverage -534.75
Dividend + Capital Expenditure Coverage -534.75

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.64
EPS -1.122
Debt/Share 3.8613
Cash/Share 2.06
Book Value/Share -1.46
Tangible BV/Share -1.46
Equity/Share -1.46
Operating Cash Flow/Share -1.111
Capital Expenditure/Share 0.002
FCF/Share -1.113

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.999
Earnings Before Tax/EBIT 1.317
Price/Fair Value -2.41
Debt/Market Cap 0.9787
Effective Tax Rate 0.1%
Enterprise Value Multiple -5.88